Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 1678

1.

[Multiple sclerosis, neuromyelitis optica and spasticity: control of specific symptoms and quality of life].

Patejdl R, Tesar S, Zettl UK.

Fortschr Neurol Psychiatr. 2014 Jul;82(7):373-85. doi: 10.1055/s-0034-1366536. Epub 2014 Jul 11. German.

PMID:
25014200
[PubMed - in process]
2.

CD19 as a molecular target in CNS autoimmunity.

Stüve O, Warnke C, Deason K, Stangel M, Kieseier BC, Hartung HP, von Büdingen HC, Centonze D, Forsthuber TG, Knappertz V.

Acta Neuropathol. 2014 Jul 4. [Epub ahead of print]

PMID:
24993505
[PubMed - as supplied by publisher]
3.

Combined Screening for Serum Anti-Nuclear and Anti-Aquaporin-4 Antibodies Improves Diagnostic Accuracy for Distinguishing Neuromyelitis Optica from Multiple Sclerosis.

Wu L, Huang D, Yang Y, Wu W.

Eur Neurol. 2014 Jul 1;72(1-2):103-108. [Epub ahead of print]

PMID:
24993096
[PubMed - as supplied by publisher]
4.

CNS demyelinating disorder with mixed features of neuromyelitis optica and multiple sclerosis in HIV-1 infection. Case report and literature review.

Delgado SR, Maldonado J, Rammohan KW.

J Neurovirol. 2014 Jul 1. [Epub ahead of print]

PMID:
24981832
[PubMed - as supplied by publisher]
5.

An immunoassay that distinguishes real neuromyelitis optica signals from a labeling detected in patients receiving natalizumab.

Sánchez Gomar I, Díaz Sánchez M, Uclés Sánchez AJ, Casado Chocán JL, Ramírez-Lorca R, Serna A, Villadiego J, Toledo-Aral JJ, Echevarría M.

BMC Neurol. 2014 Jul 1;14(1):139. [Epub ahead of print]

PMID:
24980919
[PubMed - as supplied by publisher]
Free Article
6.

Development of a cell-based assay for the detection of anti-aquaporin 1 antibodies in neuromyelitis optica spectrum disorders.

Long Y, Zheng Y, Shan F, Chen M, Fan Y, Zhang B, Gao C, Gao Q, Yang N.

J Neuroimmunol. 2014 Jun 12. pii: S0165-5728(14)00174-X. doi: 10.1016/j.jneuroim.2014.06.003. [Epub ahead of print]

PMID:
24972850
[PubMed - as supplied by publisher]
7.

Seronegative Neuromyelitis Optica Spectrum - The challenges on disease definition and pathogenesis.

Sato DK, Callegaro D, Lana-Peixoto MA, Nakashima I, Fujihara K.

Arq Neuropsiquiatr. 2014 Jun;72(6):445-50.

PMID:
24964112
[PubMed - in process]
Free Article
8.

Variants of autophagy-related gene 5 are associated with neuromyelitis optica in the Southern Han Chinese population.

Cai PP, Wang HX, Zhuang JC, Liu QB, Zhao GX, Li ZX, Wu ZY.

Autoimmunity. 2014 Jun 23:1-4. [Epub ahead of print]

PMID:
24953774
[PubMed - as supplied by publisher]
9.

Neuromyelitis optica spectrum disorders associated with other autoimmune diseases.

Freitas E, Guimarães J.

Rheumatol Int. 2014 Jun 22. [Epub ahead of print]

PMID:
24952418
[PubMed - as supplied by publisher]
10.

Systemic Lupus Erythematosus (SLE) Complicated by Neuromyelitis Optica (NMO - Devic's Disease): Clinic-Pathological Report and Review of the Literature.

Adawi M, Bisharat B, Bowirrat A.

Clin Med Insights Case Rep. 2014 Jun 2;7:41-7. doi: 10.4137/CCRep.S15177. eCollection 2014.

PMID:
24948869
[PubMed]
Free PMC Article
11.

An epidemiological study of neuromyelitis optica in Isfahan.

Etemadifar M, Dashti M, Vosoughi R, Abtahi SH, Ramagopalan SV, Nasr Z.

Mult Scler. 2014 Jun 2. pii: 1352458514537699. [Epub ahead of print] No abstract available.

PMID:
24948686
[PubMed - as supplied by publisher]
12.

Etiologic Spectrum and Prognosis of Longitudinally Extensive Transverse Myelopathies.

Cobo-Calvo A, Alentorn A, Mañé Martínez MA, Bau L, Matas E, Bruna J, Romero-Pinel L, Martínez-Yélamos S.

Eur Neurol. 2014 Jun 14;72(1-2):86-94. [Epub ahead of print]

PMID:
24942967
[PubMed - as supplied by publisher]
13.

No association between identified multiple sclerosis non-MHC risk loci and neuromyelitis optica.

Liu QB, Li ZX, Zhao GX, Yu H, Wu ZY.

Neurosci Bull. 2014 Jun 13. [Epub ahead of print]

PMID:
24927785
[PubMed - as supplied by publisher]
14.

Autoimmune Aquaporin-4 Myopathy in Neuromyelitis Optica Spectrum.

Guo Y, Lennon VA, Popescu BF, Grouse CK, Topel J, Milone M, Lassmann H, Parisi JE, Pittock SJ, Stefoski D, Balabanov R, Lucchinetti CF.

JAMA Neurol. 2014 Jun 9. doi: 10.1001/jamaneurol.2014.775. [Epub ahead of print]

PMID:
24911400
[PubMed - as supplied by publisher]
15.

Visual Outcomes in Pediatric Optic Neuritis.

Wan MJ, Adebona O, Benson LA, Gorman MP, Heidary G.

Am J Ophthalmol. 2014 Jun 4. pii: S0002-9394(14)00325-0. doi: 10.1016/j.ajo.2014.05.036. [Epub ahead of print]

PMID:
24907434
[PubMed - as supplied by publisher]
16.

Cortical Thinning Correlates with Cognitive Change in Multiple Sclerosis but not in Neuromyelitis Optica.

Liu Y, Xie T, He Y, Duan Y, Huang J, Ren Z, Gong G, Wang J, Ye J, Dong H, Butzkueven H, Shi FD, Shu N, Li K.

Eur Radiol. 2014 Jun 7. [Epub ahead of print]

PMID:
24906701
[PubMed - as supplied by publisher]
17.

The top clinical trial opportunities in therapeutic apheresis and neurology.

Morgan SM, Shaz BH, Pavenski K, Meyer EK, Delaney M, Szczepiorkowski ZM.

J Clin Apher. 2014 Jun 5. doi: 10.1002/jca.21339. [Epub ahead of print]

PMID:
24899381
[PubMed - as supplied by publisher]
18.

Neurologic indications for therapeutic plasma exchange: 2013 update.

Gwathmey K, Balogun RA, Burns T.

J Clin Apher. 2014 May 31. doi: 10.1002/jca.21331. [Epub ahead of print]

PMID:
24890467
[PubMed - as supplied by publisher]
19.

Poor responses to interferon-Beta treatment in patients with neuromyelitis optica and multiple sclerosis with long spinal cord lesions.

Wang KC, Lin KH, Lee TC, Lee CL, Chen SY, Chen SJ, Chin LT, Tsai CP.

PLoS One. 2014 Jun 2;9(6):e98192. doi: 10.1371/journal.pone.0098192. eCollection 2014.

PMID:
24887452
[PubMed - in process]
Free PMC Article
20.

Neuromyelitis optica presenting with relapses under treatment with natalizumab: a case report.

Lee DH, Laemmer AB, Waschbisch A, Struffert T, Maihöfner C, Schwab S, Linker RA.

J Med Case Rep. 2014 May 19;8(1):155. doi: 10.1186/1752-1947-8-155.

PMID:
24886528
[PubMed - in process]
Free PMC Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk